Literature DB >> 23211763

Antibacterial activity of probiotic candidates for oral health.

J Samot1, C Badet.   

Abstract

The aim of this study was to determine the probiotic potential of autochthonous oral lactobacilli. For this, 66 strains were screened for antibacterial activity against two cariogenic strains (Streptococcus mutans and Actinomyces viscosus) and two periodontopathogenic strains (Fusobacterium nucleatum and Porphyromonas gingivalis). The inhibitory activity was investigated with the agar overlay technique. Positive results led us to explore some mechanisms of action. The ability to produce H(2)O(2) and the glycerol dehydratase gene were searched among all the strains. The gassericin A gene was checked among the Lactobacillus gasseri. All the tested strains inhibited S. mutans and A. viscosus; only one did not inhibited F. nucleatum and 52 strains inhibited slightly the growth of P. gingivalis. No inactivation of antibacterial activity was observed after treatment with proteinase K. The gene of the gassericin A was not found in any strain. Only one strain showed a 275-bp amplicon corresponding to the Glycerol Dehydratase gene. This strain has been identified by DNA 16S sequencing as a L. gasseri. Among the 66 tested strains, 7 produced hydrogen peroxide. Our findings suggest that in addition to the previous results, some of the autochthonous oral lactobacilli tested could be considered as suitable probiotics.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23211763     DOI: 10.1016/j.anaerobe.2012.11.007

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  12 in total

1.  Recovery of Viable Bacteria from Probiotic Products that Target Oral Health.

Authors:  Jeffrey A Banas; Eric T Popp
Journal:  Probiotics Antimicrob Proteins       Date:  2013-09       Impact factor: 4.609

2.  Antibacterial Activity of Lactic Acid Producing Leuconostoc mesenteroides QZ1178 Against Pathogenic Gallibacterium anatis.

Authors:  Hua Zhang; HePing HuangFu; Xing Wang; ShanShan Zhao; Yuan Liu; Haoxin Lv; GuangYong Qin; Zhongfang Tan
Journal:  Front Vet Sci       Date:  2021-04-22

3.  Potent antagonistic activity of Egyptian Lactobacillus plantarum against multiresistant and virulent food-associated pathogens.

Authors:  Lamiaa A Al-Madboly; Abeer K Abdullah
Journal:  Front Microbiol       Date:  2015-05-12       Impact factor: 5.640

4.  Dynamic interactions of neutrophils and biofilms.

Authors:  Josefine Hirschfeld
Journal:  J Oral Microbiol       Date:  2014-12-17       Impact factor: 5.474

5.  Mature Biofilm Degradation by Potential Probiotics: Aggregatibacter actinomycetemcomitans versus Lactobacillus spp.

Authors:  Norzawani Jaffar; Yuya Ishikawa; Kouhei Mizuno; Toshinori Okinaga; Toshinari Maeda
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

Review 6.  Mechanisms and therapeutic effectiveness of lactobacilli.

Authors:  Alessandro Di Cerbo; Beniamino Palmieri; Maria Aponte; Julio Cesar Morales-Medina; Tommaso Iannitti
Journal:  J Clin Pathol       Date:  2015-11-17       Impact factor: 3.411

7.  Interactions between Lactobacillus rhamnosus GG and oral micro-organisms in an in vitro biofilm model.

Authors:  Qingru Jiang; Iva Stamatova; Veera Kainulainen; Riitta Korpela; Jukka H Meurman
Journal:  BMC Microbiol       Date:  2016-07-12       Impact factor: 3.605

Review 8.  Probiotics: A Promising Role in Dental Health.

Authors:  Sari A Mahasneh; Adel M Mahasneh
Journal:  Dent J (Basel)       Date:  2017-09-27

9.  Characterization of Antibacterial Cell-Free Supernatant from Oral Care Probiotic Weissella cibaria, CMU.

Authors:  Hae-Soon Lim; Ji-Eun Yeu; Sang-Phil Hong; Mi-Sun Kang
Journal:  Molecules       Date:  2018-08-09       Impact factor: 4.411

Review 10.  Potential Use of Biotherapeutic Bacteria to Target Colorectal Cancer-Associated Taxa.

Authors:  Garreth W Lawrence; Máire Begley; Paul D Cotter; Caitriona M Guinane
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.